David Hicks, MD
Anatomic Pathology · Rochester, NYNPI 1386617157
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by AstraZeneca at 45.9% of the total. Reporting peaked in 2019 at $44,458 and has fallen 71.4% since, to $12,711 in 2025. Among anatomic pathology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $1218.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$78K
- Genentech USA, Inc.$31K
- E.r. Squibb & Sons, L.L.C.$26K
- Ventana Medical Systems, Inc.$11K
- Merck$5K
- Astrazeneca UK Limited$5K
- plus $13K from 8 others
What the payments were for
- Consulting fees$96,68657%
- Speaking & faculty fees$53,07431%
- Travel & lodging$13,8908%
- Food & beverage$1,7351%
- Education$3,9792%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 54 | $77,656 |
| Genentech USA, Inc. | 22 | $31,141 |
| E.r. Squibb & Sons, L.L.C. | 26 | $25,627 |
| Ventana Medical Systems, Inc. | 5 | $11,300 |
| Merck | 8 | $5,310 |
| Astrazeneca UK Limited | 2 | $5,143 |
| Daiichi Sankyo Inc. | 9 | $4,529 |
| Siemens Medical Solutions USA, Inc. | 1 | $3,919 |
| Agilent Technologies, Inc. | 1 | $3,000 |
| Eli Lilly | 1 | $700 |
| F. Hoffmann-la Roche AG | 1 | $700 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $144 |
| Roche Diagnostics Corporation | 1 | $125 |
| Novartis | 1 | $71 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enhertu$40,171
- BENCHMARK IHC/ISH PLATFORMS & REAGENTS$6,200
- OPDIVO$4,861
- INFORM HER2 Dual ISH DNA Probe Cocktail$4,800
- SPRYCEL$3,966
- ADVIA Centaur XP Analyzer$3,919
- LYNPARZA$3,025
- PD-L1 IHC 28-8 pharmDx$3,000
- Avastin$1,695
- Herceptin$1,695
- Lucentis$1,695
- Rituxan$1,695
- Tamiflu$1,695
- PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody$125
How this compares
$169,365 in reported general payments places this provider in the 95th percentile of 152 anatomic pathology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology in Rochester
- Meenakshi BansalRochester$22K
- Hiroshi MiyamotoRochester$19K
- Robert PierceRochester$650
- Jeremy SegalNew York$89K
- Richard AxelNew York$79K
- Thaer KhouryBuffalo$74K
- Marc LadanyiNew York$68K
- Thomas WrightIrvington$53K
- Antonia SepulvedaNy$49K
- Laura TangNew York$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.